Trial Profile
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2011
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary) ; Vancomycin
- Indications Bacteraemia; Methicillin-resistant Staphylococcus aureus infections; Pneumonia; Skin and soft tissue infections; Urinary tract infections
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.